SADIA DAR: Open Payments
NPI 1326115577 · SMYRNA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 19 payments from 12 companies in 2025. Trend: 2023 $446 · 2024 $469 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $76 |
| Lilly USA, LLC | 3 | $48 |
| Astellas Pharma US Inc | 2 | $44 |
| Exact Sciences Corporation | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| PFIZER INC. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
Products named: SHINGRIX, Veozah, Cologuard Collection Kit, ZEPBOUND, AREXVY, JARDIANCE, LAGEVRIO, PREVNAR 20.
Industry payments across TN — which companies pay providers there.
